ZNF783 Gene Prostate Cancer Genetic Test
Cost: AED 4400.0
Test Name: ZNF783 Gene Prostate Cancer Genetic Test
Components:
- Price: AED 4400.0
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Cancer
- Doctor: Oncologist
- Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for ZNF783 Gene Prostate Cancer NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ZNF783 Gene Prostate Cancer NGS Genetic DNA Test gene ZNF783.
Test Details:
The ZNF783 gene is a zinc finger protein-coding gene that has been found to be associated with prostate cancer. NGS (Next-Generation Sequencing) genetic tests can be used to analyze the DNA sequence of the ZNF783 gene and identify any genetic variations or mutations that may be present.
Prostate cancer is a common type of cancer that affects the prostate gland in men. Genetic testing can help identify individuals who may be at an increased risk of developing prostate cancer due to specific genetic mutations or variations.
By analyzing the ZNF783 gene and other relevant genes, NGS tests can provide valuable information about an individual’s genetic predisposition to prostate cancer.
NGS genetic tests for prostate cancer can be performed using a sample of DNA, typically obtained through a blood or saliva sample. The DNA is then sequenced using advanced sequencing technologies, allowing for the detection of genetic variations in the ZNF783 gene and other relevant genes associated with prostate cancer.
The results of a ZNF783 gene NGS genetic test can provide important information about an individual’s risk of developing prostate cancer. This information can be used for personalized screening and prevention strategies, as well as informing treatment decisions for individuals already diagnosed with prostate cancer.
It is important to note that genetic testing for prostate cancer is not recommended for everyone. It is typically reserved for individuals with a strong family history of prostate cancer or those who have already been diagnosed with the disease.
Genetic counseling is often recommended before and after genetic testing to help individuals understand the implications of the test results and make informed decisions about their healthcare.
Overall, NGS genetic testing for the ZNF783 gene can provide valuable information about an individual’s risk of developing prostate cancer and guide personalized healthcare decisions. However, it is important to consult with a healthcare professional or genetic counselor to determine if genetic testing is appropriate for you and to understand the limitations and implications of the test results.
Test Name | ZNF783 Gene Prostate cancer Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ZNF783 Gene Prostate cancer NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ZNF783 Gene Prostate cancer NGS Genetic DNA Test gene ZNF783 |
Test Details |
The ZNF783 gene is a zinc finger protein-coding gene that has been found to be associated with prostate cancer. NGS (Next-Generation Sequencing) genetic tests can be used to analyze the DNA sequence of the ZNF783 gene and identify any genetic variations or mutations that may be present. Prostate cancer is a common type of cancer that affects the prostate gland in men. Genetic testing can help identify individuals who may be at an increased risk of developing prostate cancer due to specific genetic mutations or variations. By analyzing the ZNF783 gene and other relevant genes, NGS tests can provide valuable information about an individual’s genetic predisposition to prostate cancer. NGS genetic tests for prostate cancer can be performed using a sample of DNA, typically obtained through a blood or saliva sample. The DNA is then sequenced using advanced sequencing technologies, allowing for the detection of genetic variations in the ZNF783 gene and other relevant genes associated with prostate cancer. The results of a ZNF783 gene NGS genetic test can provide important information about an individual’s risk of developing prostate cancer. This information can be used for personalized screening and prevention strategies, as well as informing treatment decisions for individuals already diagnosed with prostate cancer. It is important to note that genetic testing for prostate cancer is not recommended for everyone. It is typically reserved for individuals with a strong family history of prostate cancer or those who have already been diagnosed with the disease. Genetic counseling is often recommended before and after genetic testing to help individuals understand the implications of the test results and make informed decisions about their healthcare. Overall, NGS genetic testing for the ZNF783 gene can provide valuable information about an individual’s risk of developing prostate cancer and guide personalized healthcare decisions. However, it is important to consult with a healthcare professional or genetic counselor to determine if genetic testing is appropriate for you and to understand the limitations and implications of the test results. |